These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
No trial status on register 2004-005207-15 Low dose muscle relaxant in intubation in children bad-data
Not reported 2005-000496-17 Atorvastatin in moderat active Crohns disease 2007-09-04 due-trials
Ongoing 2007-007661-20 Which is the optimal treatment for miscarriage with a gestational sac in the uterus and which factors can predict if the treatment will be successful? not-yet-due
Completed, but no date Terminated 2008-000306-36 Nexavar in Relapsed Peripheral T-cell Non-Hodgkins Lymphoma bad-data
Ongoing 2008-001871-31 Local steroid injection in the treatment of idiopathic carpal tunnel syndrome: A randomized double-blind placebo-controlled trial among patients planned for surgical treatment not-yet-due
Ongoing 2010-018604-85 Randomized study of yohimbine treatment for type 2 diabetes patients carrying a specific genetic risk variant not-yet-due
Ongoing 2011-001264-22 Eplerenone and spironolactone in male patients with ascites due to liver cirrhosis. A Swedish prospective randomized multicenter study of efficacy and endocrinologic side effects. not-yet-due
Ongoing 2013-002895-42 Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma (GITS Ma... not-yet-due
Ongoing 2013-004224-10 Prospective randomized trial comparing the effects of oxytocin and carbetocin on circulation and vascular tone at cesarean section not-yet-due
Ongoing 2016-000235-40 Stopping anti-TNF treatment in Crohn’s and Colitis patients in remission not-yet-due
Ongoing 2016-004120-39 An experimental pilot study on immune and inflammatory biomarkers in patients with advanced prostatecancer treated with degarelix vs. GnRH agonist and with cardiovascular disease not-yet-due
Ongoing 2017-002008-28 A prospective open label study to evaluate not-yet-due